Instrument Inactif

Communiqués HC2 Holdings Inc Nyse MKT

Actions

HCHC

US4041391073

Construction et ingénierie

Communiqués

06/08	INNOVATE: Q2 Earnings Snapshot	AQ
06/08	INNOVATE Corp. Announces Second Quarter 2026 Results	AQ
03/08	INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th	AQ
08/07	INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend	AQ
01/06	INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting	AQ
14/05	INNOVATE: Q1 Earnings Snapshot	AQ
14/05	INNOVATE : Earnings Presentation (Q1 2026 Earnings Webcast FINAL)	PU
14/05	INNOVATE Corp. Announces First Quarter 2026 Results	AQ
27/04	INNOVATE Corp. to Report First Quarter 2026 Results on May 14th	AQ
06/04	INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend	AQ
31/03	MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation	AQ
26/03	INNOVATE: Q4 Earnings Snapshot	AQ
26/03	INNOVATE : Earnings Presentation (VATE Q4 2025 Earnings Webcast vFINAL 3.26.26)	PU
26/03	INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results	AQ
16/03	INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th	AQ
10/02	Transdermal GFR Article Recognized as One of Five 2025 Editors’ Choice Articles by Journal of the American Society of Nephrology (JASN)	AQ
02/02	INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend	AQ
16/12	MediBeacon® Next Generation TGFR™ System Receives FDA Approval	AQ
12/11	INNOVATE : Earnings Presentation (VATE Q3 2025 Earnings Webcast vF)	PU
12/11	INNOVATE: Q3 Earnings Snapshot	AQ
12/11	INNOVATE Corp. Announces Third Quarter 2025 Results	AQ
22/10/25	INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th	AQ
21/10/25	MediBeacon receives regulatory approval to sell the Transdermal GFR System in China	AQ
16/10/25	INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend	AQ
09/09/25	INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation	AQ